Health

Mid-week Links

• Health

Mid-week Links

Ak December 5, 2025

Licensing racket. There is no meta monopoly. KFF debate on drug pricing in the US. Use of...

Read More Read more about Mid-week Links

NICE raises willingness to pay for health gains for first time since 1999 – Healthcare Economist

• Health

NICE raises willingness to pay for health gains for first time since 1999 – Healthcare Economist

Ak December 2, 2025

The same news has come from Britain today. A press release from the United Kingdom Government stated:...

Read More Read more about NICE raises willingness to pay for health gains for first time since 1999 – Healthcare Economist

Quantifying treatment value under IRA – Healthcare Economist

• Health

Quantifying treatment value under IRA – Healthcare Economist

Ak November 29, 2025

This is the title of my new publication published today subtitled “A case study of rifaximin for...

Read More Read more about Quantifying treatment value under IRA – Healthcare Economist

Medicare Drug Price Negotiation Results: 2027 – Healthcare Economist

• Health

Medicare Drug Price Negotiation Results: 2027 – Healthcare Economist

Ak November 26, 2025

Today, the Centers for Medicare & Medicaid Services (CMS) released the results...

Read More Read more about Medicare Drug Price Negotiation Results: 2027 – Healthcare Economist

Friday Links

• Health

Friday Links

Ak November 23, 2025

The impact of scope of practice laws in anesthesia. Improvements in PBM. UK COVID response: “Too little,...

Read More Read more about Friday Links

How will new H-1B fees impact rural hospitals? – Healthcare Economist

• Health

How will new H-1B fees impact rural hospitals? – Healthcare Economist

Ak November 20, 2025

On September 19, 2025, an executive order increased the fee for new...

Read More Read more about How will new H-1B fees impact rural hospitals? – Healthcare Economist

Is Direct to Consumer (DTC) drug pricing an effective way to make drugs more affordable? – Healthcare Economist

• Health

Is Direct to Consumer (DTC) drug pricing an effective way to make drugs more affordable? – Healthcare Economist

Ak November 17, 2025

This is a recent incident biospace The article is titled “How effective...

Read More Read more about Is Direct to Consumer (DTC) drug pricing an effective way to make drugs more affordable? – Healthcare Economist

MFN comes to Medicaid under the GENEROUS program – Healthcare Economist

• Health

MFN comes to Medicaid under the GENEROUS program – Healthcare Economist

Ak November 14, 2025

Last week, CMS announced the GENERAS (cost-cutting for US Medicaid) model. The...

Read More Read more about MFN comes to Medicaid under the GENEROUS program – Healthcare Economist

ISPOR Europe 2025! – Healthcare Economist

• Health

ISPOR Europe 2025! – Healthcare Economist

Ak November 11, 2025

Excited to wrap up day one at ISPOR Europe in Glasgow, Scotland....

Read More Read more about ISPOR Europe 2025! – Healthcare Economist

How often do US commercial health plans apply coverage restrictions to cell and gene therapies? – Healthcare Economist

• Health

How often do US commercial health plans apply coverage restrictions to cell and gene therapies? – Healthcare Economist

Ak November 8, 2025

That’s the question a new paper by Chambers et al. (2025) aims...

Read More Read more about How often do US commercial health plans apply coverage restrictions to cell and gene therapies? – Healthcare Economist